Cite
Longitudinal effect of disease-modifying therapy on tricuspid regurgitant velocity in children with sickle cell anemia.
MLA
Rai, Parul, et al. “Longitudinal Effect of Disease-Modifying Therapy on Tricuspid Regurgitant Velocity in Children with Sickle Cell Anemia.” Blood Advances, vol. 5, no. 1, Jan. 2021, pp. 89–98. EBSCOhost, https://doi.org/10.1182/bloodadvances.2020003197.
APA
Rai, P., Joshi, V. M., Goldberg, J. F., Yates, A. M., Okhomina, V. I., Penkert, R., Ataga, K. I., Kang, G., & Hankins, J. S. (2021). Longitudinal effect of disease-modifying therapy on tricuspid regurgitant velocity in children with sickle cell anemia. Blood Advances, 5(1), 89–98. https://doi.org/10.1182/bloodadvances.2020003197
Chicago
Rai, Parul, Vijaya M Joshi, Jason F Goldberg, Amber M Yates, Victoria I Okhomina, Rhiannon Penkert, Kenneth I Ataga, Guolian Kang, and Jane S Hankins. 2021. “Longitudinal Effect of Disease-Modifying Therapy on Tricuspid Regurgitant Velocity in Children with Sickle Cell Anemia.” Blood Advances 5 (1): 89–98. doi:10.1182/bloodadvances.2020003197.